Sight-Savers in Future near: New Drugs in Horizon for Vitreo-Retinal Pathologies

Vitreo-retinal pathologies have remained the Achilles' heels for the ophthalmologists since time immemorial. Changing lifestyles, enhanced longevity and better access to specialist ophthalmic care heralded an era of noncommunicable ocular diseases. Precise diagnostic modalities viz. optical coherence tomography (OCT) and OCT-angiography have simplified the diagnostic algorithm of entities like diabetic macular edema (DME), age-related macular degeneration (ARMD), choroidal neovascular membrane (CNVM), retinal vascular occlusions (RVO) and vitreo-macular tractions (VMT).